P2 trial with only 42 cohorts....(IMO, it's obvious that the author of that article has an interest in Matinas). L-O-N-G road ahead of them before, (if ever), that drug would be approved. They still need to do P3 study, which as any biotech investor will tell you, is expensive and fraught with myriad risk. Vascepa, on the other hand, has a safety profile equal to placebo, has passed it's P3 trials and is FDA approved.
Judge Moss ruled against FDA and in favor of Amarin on NCE issue, and, my dear little shorty friends, scripts are up. you probably ought to cover rather than simply bash & whine. (Get ready for your margin call.)
I'm guessing that you meant to spell overruled correctly, I am also guessing that you probably flunked the essay portion of your bar exam due to a lack of analytical skills that were further compromised by your limited study of the actual, pertinent laws. Without attempting to over-tax your brain, I would suggest that you learn a bit more about law and procedure. Yes ...things can be drawn out, continuances granted etc. but I assure you, this issue will not gather dust....
Guessing that you didn't do so well in terms of passing the bar exam or learning how to parse case law or precedents, my friend. In the future, I'd suggest that you consider limiting your posts to those issues and events wherein you actually have some modicum of technical knowledge.
Looks like you'll have be going back to the blood-bank to get your wine money again this week, tradingnutt.
BTW: Have you noticed that 21.6 MIL shares traded today at a 19% pps increase? Do you even know what the NCE ruling by the court is? I'd suggest that you study trading and the market a little more and spend a little less time spouting nonsense. Your credibility is, frankly, nonexistent. BTW: Good luck with the margin call :-)
According to the website plainsite org/attorneys/united-states-department-of-justice/ellen-london/ , atty. London doesn't exactly have a record of "hitting them out of the park"...
Hey trading nutt... why don't you actually present some news or facts rather than your relentless, asinine bashes. I understand that you're worried about your short position, but simply trying to clog up the board really isn't going to "move the needle" at all. I'm sure that it will be difficult for you to come to grips with this, but truly,... you're not even helping yourself with such behavior...it simply make you look increasingly more and more like a desperate fool.
When shorts start posting things like: XYZ stock sucks, XYZ stock is crashing, Sell XYZ etc but don't put any new news or material events behind their ramblings, it's pretty indicative that they are worried about their short position.
By the way, judging by tradernut's et al postings, shorts are suddenly VERY nervous.
FDA will be very hard pressed to rebut C&B's presentation of the facts in this case. In short, it looks like FDA will be holding just a knife when they show up at a proverbial gun fight.